Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
An index measures a segment of the stock market, aggregating prices or returns. Learn what it reveals about market trends.
27,998 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
As IPO risk rises in 2026, Altria’s reliable 6% dividend and decades of payout growth position it as a steadier optio...
The U.S. debt machine is getting harder to stabilize as deficits rise and the Treasury market faces strain. Bitcoin i...
A growing share of seniors are postponing downsizing due to costs and limited options. The result is less housing tur...
Investors are watching SpaceX's potential public listing as markets show cautious appetite for big IPOs. Historical t...
Traders are turning to a wheel-style IBIT options strategy that converts Bitcoin's volatility into premium. The appro...
SpaceX's blockbuster IPO delivered record cash and a sky-high valuation, but a $17 billion mispricing—the billion mis...
Two veteran reporters clash over OpenAI’s potential IPO. One sees missteps and scope creep; the other argues leaks dr...
A prominent billionaire asserts the market is underestimating how far the Federal Reserve may go with rate cuts. This...
U.S. equities closed the second quarter with a double‑digit rally, led by AI-driven tech names. Yet analysts warn tha...
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
A private AI company launches a $0.85-per-share pre-IPO round, inviting accredited investors to join pre-IPO before t...